Once converted to prednisolone in your liver, this corticosteroid medicine works through several key mechanisms: Anti-Inflammatory Action Prednisone significantly reduces inflammation by: Inhibiting the release of pro-inflammatory substances like cytokines and prostaglandins Stabilizing cell membranes to prevent tissue damage Reducing swelling, redness, and pain associated with inflammation Immune System Suppression The medication suppresses immune system activity by: Reducing the migration and activity of white blood cells Decreasing T and B lymphocyte function Preventing the immune system mistakenly attacks on healthy tissues in autoimmune conditions Metabolic Effects Prednisone influences your bodys metabolism by: Promoting glucose production from non-carbohydrate sources Affecting protein breakdown and fat redistribution Regulating your bodys response to stress and inflammation ADZxxdfx5txcxc Medical Conditions Treated with Prednisone Prednisone is used to treat numerous conditions, including: Inflammatory Conditions Rheumatoid arthritis and other joint disorders Multiple sclerosis flare-ups Psoriasis and severe skin conditions Inflammatory bowel disease (Crohns disease and ulcerative colitis) Autoimmune Disorders Systemic lupus erythematosus Myasthenia gravis Autoimmune hemolytic anemia Idiopathic thrombocytopenic purpura Respiratory Conditions Severe asthma exacerbations Chronic obstructive pulmonary disease (COPD) flare-ups Allergic reactions, including anaphylaxis (combined with other treatments) Pneumonia with significant inflammation Kidney Disorders Those with kidney disease may be prescribed prednisone for: Nephrotic syndrome to reduce protein in urine Lupus nephritis Prevention of organ rejection after kidney transplant Cancer and Blood Disorders Prednisone is used to treat certain types of: Leukemia and lymphoma Multiple myeloma As part of combination chemotherapy regimens Forms and Dosages of Prednisone Prednisone is available in several dosage forms to accommodate different patient needs and treatment requirements
The modified treatment-regimen estimand represents the estimated average treatment effect regardless of adherence to study intervention or initiation of prohibited weight management treatments, and assuming participants who took rescue orforglipron would not have received any additional improvement from their randomized study treatment
WilliamsKHBurnsKConstantinoMShackelNAPrakosoEWongJet al
However, outliers were analyzed for these correlations using the interquartile range (IQR) method
P for interaction for CV events = .95
PT-141 should not be injected more than twice a week or eight times per month, Staheli cautions
